When comparing long-term kidney outcomes separately in the AKI and non-AKI groups, the decline in eGFR was higher in the sacubitril-valsartan group compared to the valsartan group within the AKI cohort; however, these differences did not reach statistical significance ( Supplementary Table 2 , available online).
← all excerpts
Cardiac and kidney outcomes after sacubitril-valsartan therapy: recovery of cardiac function relative to kidney function decline.
1
—
—